| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | -0.0087 | 0.9 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.0072 | 0.9 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.0096 | 0.9 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | Methotrexate | GDSC1000 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.0068 | 0.9 |
| mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.0077 | 0.9 |
| mRNA | BIRB 0796 | FIMM | pan-cancer | AAC | -0.033 | 0.9 |
| mRNA | regorafenib | CTRPv2 | pan-cancer | AAC | 0.0067 | 0.9 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | -0.0056 | 0.9 |